(Q36552209)

14 August 2017

0 references

1 reference

title

A meta-analysis comparing trials of antimuscarinic medications funded by industry or not. (English)

1 reference

14 August 2017

Paul K Tulikangas

1

1 reference

14 August 2017

Amanda Ayers

series ordinal

2

1 reference

14 August 2017

David M O'Sullivan

series ordinal

3

1 reference

14 August 2017

publication date

1 August 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

98

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

377-380

1 reference

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Tolterodine: as effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

A randomized controlled trial of tolterodine and oxybutynin on tolerability and clinical efficacy for treating Chinese women with an overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Tolterodine: a safe and effective treatment for older patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Problems and Limitations in Conducting Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

Behavioral vs Drug Treatment for Urge Urinary Incontinence in Older Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06254.X

10.1111/J.1464-410X.2006.06254.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference